Free tool
Oncology stocks
We cover 4 companies grouped under the Oncology theme. The median market value in the group is $89.72M. Across the group, the median move over the past trading day is −0.49%. Price change over the past year runs from −62.1% to +15.8% across the middle 80 percent of the group, with a median of −12.3%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
4 of 319 companies match these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return | Next report |
|---|---|---|---|---|---|---|
| IPHA | Innate Pharma S.A. | $2.27 | +28.10% | +24.73% | +1.34% | Sep 17, 2026 |
| ANIX | Anixa Biosciences, Inc. | $3.66 | +5.78% | +15.82% | +22.00% | Sep 9, 2026 |
| IMMP | Immutep Limited | $0.38 | +0.50% | −87.05% | −77.54% | Sep 2, 2026 |
| BLRX | BioLineRx Ltd. | $2.85 | +1.06% | +1.79% | −25.97% | Aug 31, 2026 |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.